Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases
- 1 November 2019
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 151-152, 130-151
Abstract
No abstract availableKeywords
Funding Information
- DST (EMR/2016/002304)
- DST (EEQ/2016/000102)
- IIIM (IIIM/2244/2018)
- CNRS
- Université Paris-Sud
This publication has 223 references indexed in Scilit:
- A Nonpeptidic Cathepsin S Activity-Based Probe for Noninvasive Optical Imaging of Tumor-Associated MacrophagesChemistry & Biology, 2012
- Polymeric Conjugates for Drug DeliveryChemistry of Materials, 2012
- Proteases as regulators of pathogenesis: Examples from the ApicomplexaBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2012
- Development of Activity-Based Probes for Cathepsin XACS Chemical Biology, 2011
- HPMA copolymers: Origins, early developments, present, and future☆Advanced Drug Delivery Reviews, 2010
- Sorting of lysosomal proteinsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Emerging functional roles of cathepsin EBiochemical and Biophysical Research Communications, 2008
- Polymer-drug conjugates: Recent development in clinical oncologyAdvanced Drug Delivery Reviews, 2008
- A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapyBioorganic & Medicinal Chemistry Letters, 2008
- Expression of Cathepsin B and L antigen and activity is associated with early colorectal cancer progressionEuropean Journal of Cancer, 2004